Does DSIP actually induce sleep?

The name describes a 1977 rabbit experiment. Human studies were small and mixed — some, like the double-blind Bes et al. trial in people with long-standing poor sleep (1992, PMID 1299794), reported positive effects on sleep measures, while other controlled work found no significant effect versus placebo. The 2006 field review remained skeptical of the sleep-factor hypothesis overall (Kovalzon & Strekalova, PMID 16539679) — a mixed record, honestly told.

Is DSIP the same as melatonin?

No. Melatonin is a hormone that signals circadian timing. DSIP is a nine-amino-acid peptide with no identified receptor and no established role in human sleep regulation — different molecule, different proposed mechanism, very different evidence bases.

Is DSIP FDA-approved?

No — not for any use. And in July 2026 the FDA's Pharmacy Compounding Advisory Committee reviewed DSIP (Emideltide) for the 503A Bulks List and did not recommend it, even as it narrowly advanced several other peptides — a documented advisory outcome.

What's in the SLEEP strip?

Per the packaging's Supplement Facts panel: DSIP 200 mcg, GABA 20 mg, 5-HTP 10 mg, and InstaRelease 3 mg (a delivery-excipient blend, not an active), 30 mint strips per box. The product is available at open checkout, and no COA is on file for it.

DSIP: What It Is & What Sleep Research Shows

Short answer: DSIP (delta sleep-inducing peptide) is the original "sleep peptide" — a nine-amino-acid molecule isolated in 1977 and named for its effect on slow-wave brain activity in rabbits. It has a fifty-year research story, a loyal following among sleep-optimization enthusiasts who commonly report deeper-feeling rest [attributed user reports], and it's the peptide anchor of our SLEEP blend.

DSIP gave the whole sleep-peptide category its name. This page is the reference our sleep coverage links back to: where DSIP came from, how it's thought to work, what the research explored, the 2026 regulatory review, and where it appears in our catalog. For the product itself, our sleep peptide strips breakdown covers the SKU.

Where DSIP came from

DSIP is a nonapeptide — Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, roughly 849 daltons — isolated in 1977 by Schoenenberger and Monnier in Basel from the cerebral venous blood of rabbits in a slow-wave state. Infused into recipient rabbits, the material increased delta-wave and spindle EEG activity — hence the name (Schoenenberger & Monnier, 1977, PMID 265572) [preclinical evidence].

It's not a hormone and not a form of melatonin — a structurally distinct small peptide with no relationship to the melatonin pathway. Its basic biology is genuinely unusual: after ~50 years, no dedicated DSIP receptor, gene, or precursor protein has been identified, which the field's definitive review (Kovalzon & Strekalova, 2006, PMID 16539679) frames as an "unresolved riddle." Unresolved is not the same as uninteresting — it's a molecule science keeps coming back to.

How it's thought to work

The research threads point toward sleep architecture — the depth and rhythm of slow-wave states — rather than sedation. Researchers have also examined DSIP in animal and pilot work on stress-hormone regulation, opioid-system interaction, and recovery contexts [preclinical evidence]. The appeal for a sleep blend is obvious: a compound studied around the brain's deep-sleep rhythms, paired with calming-pathway co-ingredients. Brand copy describes the SLEEP formula as "supporting the conditions for sleep, not sedating" [brand claim — unverified] — which is, honestly, a thoughtful design philosophy.

What the research has explored

DSIP is a well-characterized nine-amino-acid peptide, sequenced and synthesized in the late 1970s, with reproducible chemistry [published human data — characterization only].
In animal models, DSIP and certain analogues altered slow-wave EEG activity [preclinical evidence].
Small human studies in the 1980s–90s explored sleep measures directly: Schneider-Helmert's group reported acute and delayed effects on human sleep behavior (1981, PMID 6895513) and 24-hour sleep-wake patterns (1987, PMID 3622582); a double-blind study in people with long-standing poor sleep (Bes et al., 1992, PMID 1299794) is among the most-cited positive trials [published human data — small, dated, mixed].

What users commonly report about DSIP-containing blends: falling asleep more easily, fewer middle-of-the-night wake-ups, waking feeling more restored [attributed user reports — unquantified].

The regulatory picture moved recently: at the FDA Pharmacy Compounding Advisory Committee meeting on July 23–24, 2026, the panel reviewed peptide nominations for the 503A Bulks List and narrowly recommended several (BPC-157, KPV, TB-500, MOTS-c, Semax, Epitalon); DSIP — under its official name Emideltide — was not among them. That's an advisory outcome, not a final rule, and our safety and sourcing pillar explains what 503A status does and doesn't mean.

Formats: research legacy, strip present

The historical research used injections. The strip format is the modern answer for nightly routines: no needles, no water, dissolves in about a minute, mint-flavored, pre-measured — the lowest-friction version of a wind-down ritual. DSIP-specific strip absorption is unmeasured, and the general framework lives on our sublingual delivery science pillar.

The honest context

One bounded passage, because sleep buyers deserve straight talk: DSIP's human studies were small, old, and produced mixed results — some positive, some null. Its fundamental biology is unresolved, no large modern trial exists, and no published research covers any strip format. Sleep is also the most expectation-sensitive outcome in the supplement world — the placebo effect on self-reported sleep is strong — so "I felt rested" proves nothing about any product, ours included. If you have persistent trouble sleeping, the strongest-evidence interventions are behavioral and clinical: a licensed provider first. Adults 18+ only, never while pregnant or nursing.

Where DSIP appears in our catalog

DSIP appears in exactly one product we carry: SLEEP sublingual strips — per the Supplement Facts panel, DSIP 200 mcg + GABA 20 mg + 5-HTP 10 mg + InstaRelease™ 3 mg per strip (InstaRelease is a named delivery-excipient blend of hydroxypropyl β-cyclodextrin, Penetratin, and sunflower lecithin — an excipient system, not an active). Thirty strips per box, mint flavor.

Two things to know: SLEEP is available at open checkout. And per our product data, SLEEP is one of five InstaMed SKUs with no COA on file, so any "third-party tested" framing for it would be unverified. The strips are sold under the InstaMed brand (Salt Lake City/Draper, Utah); we sell them as an authorized reseller.

The bottom line

DSIP is the molecule that started the sleep-peptide conversation — a real, well-characterized compound with a fifty-year research story and a design philosophy we like: support the conditions for sleep rather than sedate. The SLEEP blend wraps it with GABA and 5-HTP — the calm and serotonin-pathway partners — in one mint strip, 30 per box. If you're building a better wind-down ritual, this is the thoughtful, transparent-paneled option.

---

Explore this cluster

The rest of the DSIP file — the study problem, the melatonin comparison, and what the sleep strip actually contains.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

DSIP and the Science of Sleep Peptides: What It Is, What the Research Shows, and What It Doesn't